申请人:——
公开号:US20030236405A1
公开(公告)日:2003-12-25
Compounds of the formula
1
and their pharmaceutically acceptable salts, wherein R
1
, R
2
, R
3
and R
4
are defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders are claimed.
本发明涉及化合物1及其药学上可接受的盐,其中R1、R2、R3和R4如规范中所定义,以及合成此类化合物的中间体,包含此类化合物的制药组合物,以及使用此类化合物治疗神经和心理障碍的方法。